NSV Partners III GP LLC, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 98,304 shares at $30.03 ($3.0M) on 2023-10-09, disclosed to the SEC on 2023-10-11.
Scheduled sale ($3.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.03 | 49,152 | $1.5M | 50.0% |
| 2 | $30.03 | 49,152 | $1.5M | 50.0% |
| Total | $30.03 avg | 98,304 | $3.0M | 100% |
| Filing → |